|
Case Number
|
Title
|
Non-Confidential Summary
|
Issued Patent
|
Lead Inventor's Website
|
|
BER_ERI.001
|
Use of Tempol in the Prevention of Photoaging
|
|
[US Patent No. 5,840,734]
|
Link
|
|
BLO_TIM.002
|
Glucosidase Inhibitors as a Treatment for Viruses that Bud from the Endoplasmic Reticulum
|
|
|
|
|
BRO_JON.001
|
The Specific Level of Expression and Localization of a Key Signaling Protein Can Dictate And Predict The Response Of The Most Commonly Used Chemotherapeutic Used In The Treatment Against Pancreatic Cancer, Ovarian Cancer And Metastatic Breast Cancer
|
NCS for BRO_JON.001 |
|
Link
|
|
CON_PAU.001
|
Use Of Magnetic Particles In The Focal Delivery Of Cells
|
|
[US Patent No. 6,203,487]
|
|
|
CRO_CAR.002
|
Compositions, Kits and Methods Relating to the Human FEZ1 Gene, a Novel Tumor Suppressor Gene
|
NCS for Croce tumor suppressor techs (CRO 2,4,5,16) |
|
|
|
CRO_CAR.004
|
The Human FHIT Gene
|
NCS for Croce tumor suppressor techs (CRO 2,4,5,16) |
[United States Patent: 7220834] [United States Patent: 6774217] [United States Patent: 6242212] [United States Patent: 5928884]
|
|
|
CRO_CAR.009
|
TCL-1 Gene And Protein And Related Methods And Compositions
|
NCS for Croce TCL-1 techs (CRO 9,15) |
|
|
|
CRO_CAR.015
|
Human Chronic Lymphocytic Leukemia Modeled in Mouse by Targeted TCL1 Expression
|
NCS for Croce TCL-1 techs (CRO 9,15) |
|
|
|
CRO_CAR.016
|
Novel Tumor Suppressor Gene and Compositions and Methods for Making and Using the Same
|
NCS for Croce tumor suppressor techs (CRO 2,4,5,16) |
|
|
|
CRO_CAR.017
|
Role of microRNA Genes In Human Cancer
|
NCS for Croce miRNA techs (CRO 17, 25) |
|
|
|
CRO_CAR.019
|
Involvement Of The ALL-1 Gene In A Solid Tumor1
|
|
[US Patent No. 5,567,586]
|
|
|
CRO_CAR.025
|
microRNA genes in cancer diagnosis and treatment
|
NCS for Croce miRNA techs (CRO 17, 25) |
|
|
|
DAN_REN.003
|
Targeting of Integration of Retroviral Vectors by Manipulation Integration Cofactors
|
NCS for DAN_REN.003 |
|
Link
|
|
DIE_BER.010
|
Recombinant Rabies for Pre- and Post-Exposure Prophylaxis
|
|
|
Link
|
|
FEL_ART.001
|
Adenosine A1 Receptor Mutations Predict Infarct Size
|
NCS for FEL_ART 001, 003 |
|
Link
|
|
FEL_ART.003
|
Use of Adenosine Receptor Subtypes as Therapeutic Targets
|
NCS for FEL_ART 001, 003 |
|
Link
|
|
HUA_ZIW.001
|
Small Molecules Inhibitor of BCL-2
|
HUA_ZIW.001, .006, .011 NCS |
[US Patent No. 6,492,389]
|
|
|
HUA_ZIW.006
|
Enhancement of Peptide Cellular Uptake
|
HUA_ZIW.001, .006, .011 NCS |
[US Patent No. 6,713,280]
|
|
|
HUA_ZIW.011
|
Synthesis of 4-H Chromene Derivatives Compounds that Bind Bcl-2 Protein and Induce Apoptosis in Tumor Cells
|
HUA_ZIW.001, .006, .011 NCS |
[US Patent No. 6,660,871]
|
|
|
IOZ_REN.001
|
A Role For Decorin In Tumor Suppression
|
|
[US Patent No. 6,524,573]
|
Link
|
|
IOZ_REN.009
|
Endorepellin, A Novel Inhibitor of Angiogenesis Derived from the Carboxyl Terminus of Perlecan
|
NCS for IOZ_REN.009 |
[US Patent No. 6,821,947]
|
Link
|
|
KAS_DAV.001
|
A Small Bowel Purgative for Wireless Capsule Endoscopy
|
NCS for KAS_DAV 001 |
|
|
|
KMI_ERI.002
|
Mammalian and Human REC2
|
|
[US Patent No. 6,410,226]
|
|
|
KMI_ERI.004
|
Chimeric Mutation Vectors Having Non-Natural Nucleotides
|
|
[US Patent No. 5,731,181] [US Patent No. 5,795,972]
|
|
|
KMI_ERI.005
|
Methods for Enhancing Gene Conversion or Genetic Repair by Chimeric Oligonucleotides
|
|
|
|
|
KMI_ERI.007
|
Compositions and Methods to Promote Homologous Recombination in Eukaryotic Cells and Organisms
|
|
[US Patent No. 5,780,296]
|
|
|
KMI_ERI.008
|
Compounds and Methods for Site-Directed Mutations in Eukaryotic Cells
|
|
[US Patent No. 5,756,325]
|
|
|
KOC_WAL.001
|
GRK2 Activity as a Therapeutic Target for Heart Failure
|
NCS for KOC_WAL.001 |
|
Link
|
|
KOP_HIL.006
|
Polypeptides Fused with Alfalfa Mosaic Virus or Ilarvirus Capsid Proteins
|
|
[US Patent No. 6,042,832] [US Patent No. 6,448,070]
|
Link
|
|
KOP_HIL.021
|
Generation of Plant-Based Recombinant Subunit Vaccine Against Smallpox
|
NCS for KOP_HIL.021 |
|
Link
|
|
KWO_SIM.001
|
Novel Tumor Suppressor Encoding Nucleic Acid, PTX1, and Methods of Use Thereof
|
NCS for KWO_SIM.001 |
[US Patent No. 6,743,603]
|
|
|
LI_ZHI.U001
|
Human Serum Albumin-based Drug Delivery and Targeting System
|
NCS for LI_ZHI.U001 |
|
|
|
MEN_SUE.002
|
Cell Migration Leading to Posterior Capsule Opacification can be Prevented by Inhibition of Src Kinase Activities
|
NCS for MEN_SUE.002 |
|
Link
|
|
OST_JEW.002
|
Intra-Peritoneal Perfusion of Oxygenated Fluorocarbons
|
|
[US Patent No. 4,657,532] [US Patent No. 4,963,130]
|
Link
|
|
PAC_MAU.005
|
Prevention and Treatment of Abnormal Ossification and Mineralization
|
NCS for PAC_MAU.005 |
|
|
|
PES_CES.001
|
Compositions And Methods For Use In Affecting Hematopoietic Stem Cell Populations In Mammals
|
|
[US Patent No. 6,586,192]
|
|
|
PES_RIC.003
|
A New Breast Cancer Suppressor: MicroRNA 17/20
|
NCS for PES_RIC.003 |
|
|
|
RAB_JOS.001
|
Development of an Enhancer/Promoter Pair for Heart Selective Gene Expression
|
NCS for RAB_JOS.001 |
|
Link
|
|
SAN_JAM.001
|
Peptides with High Affinity for Heparin and for Proteoglycans to be used to Promote Endothelialization of Synthetic Vascular Graft Surfaces, or to Target the Delivery of Drugs to Cell Surfaces
|
NCS for SAN_JAM.001, .002 |
[US Patent No. 6,855,801]
|
Link
|
|
SAN_JAM.002
|
Peptides that Neutralize Heparin or Proteoglycans, or Promote Cell Adhesion or Drug Delivery
|
NCS for SAN_JAM.001, .002 |
[US Patent No. 7,259,140]
|
Link
|
|
SAN_JAM.003
|
Novel Method to Rapidly Promote Angiogenesis
|
NCS for SAN_JAM.003 |
|
Link
|
|
SCH_JAY.001
|
Treatment of Parkinson's Disease with Oligonucleotide and Triplex Technology
|
NCS for SCH_JAY.001 and SCH_JAY.002 |
|
Link
|
|
SCH_JAY.002
|
Partial Agonists at the Glycine Modulatory Site of the NMDA Receptor for Treating Cognitive Dysfunction in Parkinson's Disease
|
NCS for SCH_JAY.001 and SCH_JAY.002 |
|
Link
|
|
SCH_JAY.004
|
Method of Treating Parkinson's Disease and Composition for the Same
|
NCS for SCH_JAY.004 |
[United States Patent: 7160913]
|
Link
|
|
SHA_KUM.013
|
Treatment of kidney disease with the Hormone Adiponectin
|
NCS for SHA_KUM.013 |
|
|
|
SIM_LAN.004
|
A Vaccine Against Botulinum that Does Not Bind to the Nervous System
|
NCS for SIM_LAN.004 |
|
Link
|
|
STR_DAV.001
|
SV40 Viral Vectors for Targeted Integration Into Cells
|
|
[US Patent No. 5,863,794]
|
Link
|
|
SUN_XIA.001
|
Implantable Sensor and System for Measurement and Control of Blood Constituent Levels
|
|
[US Patent No. 5,995,860] [US Patent No. 6,122,536]
|
|
|
SYK_YUR.004
|
Invention of a Novel Serum Free Media for Cultivation of Hybridoma Cells to Achieve Production of Highly Homogenous Monoclonal Antibodies (MAb) in Preparative Scale
|
|
|
Link
|
|
THA_MAT.002
|
Lipid soluble radioactive metal chelates for tumor therapy
|
NCS for THA_MAT.002 |
[US Patent No. 6,685,913]
|
Link
|
|
THO_JEF.001
|
Nitric Oxide Donor Compositions, Methods, Apparatus, and Kits for Alleviating Vasoconstriction and Vasospasm in a Mammal
|
|
[US Patent No. 6,358,536]
|
|
|
ZAL_AND.002
|
Inhibition Of Extracellular Matrix Synthesis By Antisense Compounds Directed To Nuclear Proto-Oncogenes
|
|
[US Patent No. 6,133,242]
|
|